FDA Inspection
Society Hill Reproductive MedicineSociety Hill Reproductive Medicine – FDA Inspection, Apr 11, 2024
Record Details
This FDA Inspection record concerns Society Hill Reproductive Medicine, with an inspection on April 11, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 95a5e9a9-9cd0-4eba-ba4d-c2599aaf66e0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1235610
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.50(a)Determination based on screening and testing
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Society Hill Reproductive Medicine
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 7, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 3, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| September 18, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 13, 2012 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Society Hill Reproductive Medicine
- FDA Inspection 1165539 - 2022-03-09
- FDA Inspection 1081928 - 2019-02-07
- FDA Inspection 999150 - 2017-02-03
- FDA Inspection 895995 - 2014-09-18
- FDA Inspection 767584 - 2012-02-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.